As of Feb 17
| -0.30 / -2.05%|
The 10 analysts offering 12-month price forecasts for Heron Therapeutics Inc have a median target of 28.50, with a high estimate of 45.00 and a low estimate of 21.00. The median estimate represents a +99.30% increase from the last price of 14.30.
The current consensus among 10 polled investment analysts is to Buy stock in Heron Therapeutics Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.